Get the Stockscreener App
319.06
0.55%
-1.78
Pre-market:
302.88
-16.18
-5.07%
Beone Medicines Ltd Adr stock is traded at $319.06, with a volume of 179.67K.
It is down -0.55% in the last 24 hours and down -15.47% over the past month.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$320.84
Open:
$320.84
24h Volume:
179.67K
Relative Volume:
0.69
Market Cap:
$35.31B
Revenue:
$4.98B
Net Income/Loss:
$69.59M
P/E Ratio:
613.93
EPS:
0.5197
Net Cash Flow:
$525.67M
1W Performance:
-1.19%
1M Performance:
-15.47%
6M Performance:
+15.38%
1Y Performance:
+0.00%
1-Day Range:
$318.09
$322.55
1-Week Range:
$315.50
$331.83
52-Week Range:
$172.67
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd Adr
Sector
Industry
Phone
41-616851900
Address
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
319.06 | 35.50B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | Truist | Buy |
| Sep-18-25 | Initiated | Barclays | Overweight |
| Apr-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-03-24 | Resumed | Morgan Stanley | Overweight |
| Sep-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Feb-06-24 | Resumed | JP Morgan | Overweight |
| Sep-12-23 | Initiated | Macquarie | Outperform |
| Aug-17-23 | Initiated | Jefferies | Buy |
| Jul-17-23 | Initiated | Citigroup | Buy |
| Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-12-23 | Initiated | Daiwa Securities | Buy |
| Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-09-22 | Resumed | JP Morgan | Overweight |
| Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Feb-07-22 | Initiated | Deutsche Bank | Buy |
| Oct-12-21 | Initiated | Bernstein | Outperform |
| Oct-06-21 | Upgrade | CLSA | Underperform → Buy |
| Mar-08-21 | Initiated | China Renaissance | Buy |
| Mar-01-21 | Downgrade | CLSA | Outperform → Underperform |
| Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Nov-06-20 | Downgrade | Maxim Group | Buy → Hold |
| Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight |
View All
Beone Medicines Ltd Adr Stock (ONC) Latest News
LMR Partners LLP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
China Universal Asset Management Co. Ltd. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) SVP Sells $107,900.00 in Stock - MarketBeat
35,910 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Axa S.A. - Defense World
Bellevue Group AG Makes New $9.37 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
35,910 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Axa S.A. - MarketBeat
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 9,377 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by American Century Companies Inc. - Defense World
8,037 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
12,338 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by American Century Companies Inc. - MarketBeat
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND - Benzinga
Temasek Holdings Private Ltd Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Nan Fung Group Holdings Ltd Makes New $3.81 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jump Financial LLC Invests $17.02 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Russell Investments Group Ltd. Acquires Shares of 13,603 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
7,707 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Tema Etfs LLC - MarketBeat
Walleye Capital LLC Purchases Shares of 36,645 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
467,590 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Marshall Wace LLP - MarketBeat
3,330 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Qtron Investments LLC - MarketBeat
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Hsbc Holdings PLC Invests $4.99 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Geode Capital Management LLC Acquires New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mackenzie Financial Corp Purchases Shares of 41,328 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Corazon (Corsee) Sanders Sells 2,627 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
Franklin Resources Inc. Purchases Shares of 16,254 BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Franklin Resources Inc. Purchases Shares of 16,254 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Director Corazon (Corsee) Sanders Sells 2,627 Shares - MarketBeat
Virtus Investment Advisers LLC Invests $389,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Legal & General Group Plc Buys Shares of 57,243 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jefferies Financial Group Inc. Purchases Shares of 2,900 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
PNC Financial Services Group Inc. Makes New $228,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
5,981 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Creative Planning - MarketBeat
16,300 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Pinpoint Asset Management Singapore Pte. Ltd. - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $9.93 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Now Covered by Truist Financial - Defense World
Barings LLC Buys New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Long Corridor Asset Management Ltd Invests $11.50 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
ProShare Advisors LLC Makes New $373,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Artisan Partners Limited Partnership Makes New $65.40 Million Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Artisan Partners Limited Partnership Makes New $65.40 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Xiaobin Wu Sells 3,991 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
5,088,279 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Primecap Management Co. CA - MarketBeat
1,500 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Alteri Wealth LLC - MarketBeat
1,500 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Alteri Wealth LLC - Defense World
BeOne Medicines (NASDAQ:ONC) Hits New 12-Month HighTime to Buy? - MarketBeat
KBC Group NV Takes $2.18 Million Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Insider Selling: BeOne Medicines (NASDAQ:ONC) COO Sells $2,286,664.86 in Stock - Defense World
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beone Medicines Ltd Adr Stock (ONC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lee Chan Henry | SVP, General Counsel |
Dec 11 '25 |
Option Exercise |
191.56 |
332 |
63,598 |
332 |
| Lee Chan Henry | SVP, General Counsel |
Dec 11 '25 |
Sale |
325.00 |
332 |
107,900 |
0 |
| Lee Chan Henry | SVP, General Counsel |
Dec 10 '25 |
Sale |
318.28 |
332 |
105,669 |
0 |
| Sanders Corazon (Corsee) D. | Director |
Nov 26 '25 |
Option Exercise |
159.03 |
2,627 |
417,772 |
2,627 |
| Sanders Corazon (Corsee) D. | Director |
Nov 26 '25 |
Sale |
340.90 |
2,627 |
895,534 |
0 |
0.91%
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):